x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

14:34

Perspectives on how novel lipid-lowering therapies...

touchPODCAST ·

2021/07/20

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by

en

19:02

Perspectives on the latest data for novel...

touchPODCAST ·

2021/07/20

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG,

en

13:01

Perspectives on the risk factors for ASCVD and...

touchPODCAST ·

2021/07/20

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia. The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This

en

14:41

Perspectives on how novel lipid-lowering therapies...

touchPODCAST ·

2021/07/20

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly

en

13:06

Perspectives on the risk factors for ASCVD and...

touchPODCAST ·

2021/07/20

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland

en

39:06

HR+/HER2- advanced breast cancer: How do the latest...

touchPODCAST ·

2021/06/30

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts in breast cancer share their opinion on the latest data which may help guide the use of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer. The experts Dr Luca Malorni - Hospital of Prato, Italy Prof. Aleix Prat - Hospital Clínic Barcelona, Spain Dr Barbara Pistilli - Gustave Roussy, Villejuif, France This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis

en

30:21

Paving the way for optimal disease control in...

touchPODCAST ·

2021/04/26

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and University of Colorado, Denver, USA This touchPODCAST is for HCPs only. This activity is funded by an

en

30:20

Paving the way for optimal disease control in...

touchPODCAST ·

2021/04/22

touchPANEL DISCUSSION for touchRESPIRATORY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and University of Colorado, Denver, USA This touchPODCAST is for HCPs only. This activity is funded by an

en

06:55

ACR 2020 – Predictors of Response in Nr‑axSpA Treated...

touchPODCAST ·

2021/03/17

touchCONGRESS for touchIMMUNOLOGY Walter Maksymowych (University of Alberta, Alberta, Canada) talks to touchIMMUNOLOGY about the results of the C-axSpAnd Study (NCT02552212). This 52-week placebo-controlled study aimed to identify demographic or baseline characteristics of patients with nr-axSpA that could be predictive of achieving a clinical response to treatment with certolizumab pegol. The abstract entitled ‘Predictors of Response in Patients with Non-Radiographic Axial Spondyloarthritis

en

33:09

MAb biosimilars for solid tumours: Perspectives for...

touchPODCAST ·

2021/03/09

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss how monoclonal antibody (MAb) biosimilars for solid tumours are developed and approved, and learn about the practical aspects of their use in oncology pharmacy. The experts Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK Dr Joseph Bubalo - Oregon Health & Science University Hospital & Clinics, Portland, USA Mr Hisanaga Nomura - Japan Agency for Medical Research and Development, Tokyo, Japan This touchPODCAST is for

en

01:06:04

Highlights from SABCS 2020 Virtual

touchPODCAST ·

2021/01/18

touchCONGRESS for touchONCOLOGY Listen to key highlights from SABCS Virtual 2020. This touchPODCAST is presented by Prof. Dr Nadia Harbeck. We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Eli Lilly. This activity is provided by touchIME. For further information

en

01:03:34

Highlights from ESMO 2020 Virtual

touchPODCAST ·

2021/01/14

touchCONGRESS for touchONCOLOGY Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly. We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Eli Lilly. This activity is provided by touchIME. For further information

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter